397 related articles for article (PubMed ID: 28077679)
1. CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.
De Ravin SS; Li L; Wu X; Choi U; Allen C; Koontz S; Lee J; Theobald-Whiting N; Chu J; Garofalo M; Sweeney C; Kardava L; Moir S; Viley A; Natarajan P; Su L; Kuhns D; Zarember KA; Peshwa MV; Malech HL
Sci Transl Med; 2017 Jan; 9(372):. PubMed ID: 28077679
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
[TBL] [Abstract][Full Text] [Related]
3. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
[TBL] [Abstract][Full Text] [Related]
4. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
[TBL] [Abstract][Full Text] [Related]
5. Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair.
Sweeney CL; Pavel-Dinu M; Choi U; Brault J; Liu T; Koontz S; Li L; Theobald N; Lee J; Bello EA; Wu X; Meis RJ; Dahl GA; Porteus MH; Malech HL; De Ravin SS
Gene Ther; 2021 Jun; 28(6):373-390. PubMed ID: 33712802
[TBL] [Abstract][Full Text] [Related]
6. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
[TBL] [Abstract][Full Text] [Related]
7. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
[TBL] [Abstract][Full Text] [Related]
9. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.
Castelli A; Susani L; Menale C; Muggeo S; Caldana E; Strina D; Cassani B; Recordati C; Scanziani E; Ficara F; Villa A; Vezzoni P; Paulis M
Stem Cells; 2019 Jul; 37(7):876-887. PubMed ID: 30895693
[TBL] [Abstract][Full Text] [Related]
10. Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells.
De Ravin SS; Brault J; Meis RJ; Liu S; Li L; Pavel-Dinu M; Lazzarotto CR; Liu T; Koontz SM; Choi U; Sweeney CL; Theobald N; Lee G; Clark AB; Burkett SS; Kleinstiver BP; Porteus MH; Tsai S; Kuhns DB; Dahl GA; Headey S; Wu X; Malech HL
Blood; 2021 May; 137(19):2598-2608. PubMed ID: 33623984
[TBL] [Abstract][Full Text] [Related]
11. Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment.
Klatt D; Ha TC; Schinke M; Selich A; Lieske A; Dahlke J; Morgan M; Maetzig T; Schambach A
Cells; 2020 Sep; 9(10):. PubMed ID: 33003308
[TBL] [Abstract][Full Text] [Related]
12. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
[TBL] [Abstract][Full Text] [Related]
13. Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease.
De Ravin SS; Reik A; Liu PQ; Li L; Wu X; Su L; Raley C; Theobald N; Choi U; Song AH; Chan A; Pearl JR; Paschon DE; Lee J; Newcombe H; Koontz S; Sweeney C; Shivak DA; Zarember KA; Peshwa MV; Gregory PD; Urnov FD; Malech HL
Nat Biotechnol; 2016 Apr; 34(4):424-9. PubMed ID: 26950749
[TBL] [Abstract][Full Text] [Related]
14. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells.
Flynn R; Grundmann A; Renz P; Hänseler W; James WS; Cowley SA; Moore MD
Exp Hematol; 2015 Oct; 43(10):838-848.e3. PubMed ID: 26101162
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expression.
Wong RL; Sackey S; Brown D; Senadheera S; Masiuk K; Quintos JP; Colindres N; Riggan L; Morgan RA; Malech HL; Hollis RP; Kohn DB
Blood; 2023 Mar; 141(9):1007-1022. PubMed ID: 36332160
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-generated p47
Wrona D; Siler U; Reichenbach J
Sci Rep; 2017 Mar; 7():44187. PubMed ID: 28287132
[TBL] [Abstract][Full Text] [Related]
18. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.
Brault J; Liu T; Liu S; Lawson A; Choi U; Kozhushko N; Bzhilyanskaya V; Pavel-Dinu M; Meis RJ; Eckhaus MA; Burkett SS; Bosticardo M; Kleinstiver BP; Notarangelo LD; Lazzarotto CR; Tsai SQ; Wu X; Dahl GA; Porteus MH; Malech HL; De Ravin SS
Front Immunol; 2022; 13():1067417. PubMed ID: 36685559
[TBL] [Abstract][Full Text] [Related]
20. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
